• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECKMAN COULTER ACCESS SARS-COV-2 IGG II; IN VITRO DIAGNOSTIC DEVICES: CORONAVIRUS SEROLOGICAL REAGENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECKMAN COULTER ACCESS SARS-COV-2 IGG II; IN VITRO DIAGNOSTIC DEVICES: CORONAVIRUS SEROLOGICAL REAGENTS Back to Search Results
Catalog Number C69057
Device Problem False Negative Result (1225)
Patient Problem Insufficient Information (4580)
Event Date 01/17/2022
Event Type  malfunction  
Event Description
On 17jan2022 the customer reported non-reactive covid igg (access sars-cov-2-igg ii, part number c69057 and lot number 124814) results were generated on the customer's dxi (unicel dxi 800 access immunoassay analyzer, part number 973100 and serial number 606051) for two patients.The non-reactive patient results were discordant to results generated using the sars-cov-2 igg ii quant abbott architect method.There was no report of change to patient care or treatment in connection with this event.The customer reported that the patients had been vaccinated against sars-cov-2, and had received supplemental doses of covishield vaccinations (specific dates of vaccinations were not provided).No other patient information was provided.The event log was provided showing substrate dispense errors which occurred before the issue occurred.System check was passing within specifications at the time of the event.It was noted that the customer was using a calibration which had flags indicating substrate reagent was expired at the time of calibration.The customer was not running quality control at the time of the event.No issues with sample integrity were reported by the customer.Sample collection, handling and processing information such as sample type, sample volume collected, sample quality, centrifugation time and speed, storage temperature and other information was not provided by the customer.
 
Manufacturer Narrative
The full identifier is (b)(4).The customer did not provide patient demographics such as age, date of birth, gender, weight, ethnicity or race.The access sars-cov-2 igg ii assay was not returned for evaluation.There were no reports of system issues at the time of the event.There was no report of issues with other assays at the time of the event.No hardware errors or flags were reported in conjunction with the event.A beckman coulter field service engineer (fse) was dispatched to the customer site to assess system performance.Fse proactively replaced duck bill valve and aspirate probes.Fse performed calibration and verified some samples.No assay issue or any hardware issues were found.Sars-cov-2 is an enveloped non-segmented positive-sense rna virus.It has several structural proteins including spike (s), envelope (e), membrane (m) and nucleocapsid (n).The spike protein (s) contains a receptor binding domain (rbd) which is responsible for recognizing the cell surface receptor, angiotensin converting enzyme-2 (ace2).It is found that the rbd of the sars-cov-2 s protein strongly interacts with the human ace2 receptor leading to endocytosis into the host cells and viral replication.The access assay detects antibodies directed against the spike protein, which are more likely to neutralize the virus.No manufacturer guarantees both a specificity and sensitivity of 100%.The concentration of sars-cov-2 igg in a given specimen determined with assays from different manufacturers can vary due to differences in assay methods, diversity of antibodies and reagent specificity.Differences in each individual assay are expected.Different vaccines do not elicit the same immune response and each patient response is different therefore differences in patient responses are expected after vaccination.The access assay is not labeled for vaccine response detection.In conclusion, the cause of this event cannot be determined with the available information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCESS SARS-COV-2 IGG II
Type of Device
IN VITRO DIAGNOSTIC DEVICES: CORONAVIRUS SEROLOGICAL REAGENTS
Manufacturer (Section D)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer (Section G)
BECKMAN COULTER
1000 lake hazeltine drive
chaska MN 55318
Manufacturer Contact
angela vettel
1000 lake hazeltine drive
chaska, MN 55318
7149613625
MDR Report Key13351297
MDR Text Key294661062
Report Number2122870-2022-00004
Device Sequence Number1
Product Code QKO
UDI-Device Identifier15099590742744
UDI-Public(01)15099590742744(17)220331(11)211001(10)124814
Combination Product (y/n)N
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/25/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2022
Device Catalogue NumberC69057
Device Lot Number124814
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/18/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/01/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-